-Acupuncture has a clinically relevant effect on chronic pain that persists over time -The effect of acupuncture cannot be explained only by placebo effects -Factors in addition to the specific effects of needling are important contributors -Referral for acupuncture treatment is a reasonable option for chronic pain patients
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Introduction
Acupuncture remains a controversial treatment for chronic pain, largely due to a provenance outside biomedicine.
Traditional acupuncture theory invokes non-anatomical structures such as meridians and non-physiological processes such as the flow of qi energy. Although many contemporary practitioners do not rely on such concepts, there remains a dearth of data on how insertion of needles at specific points on the body could lead to long-term decreases in pain.
Acupuncture undoubtedly has short-term physiological effects, several of which are relevant to pain 7, 76, 119 , but there is as yet no explanation as to how such effects could persist.
We previously reported an individual patient data meta-analysis of high-quality trials of acupuncture for chronic pain. 92 Differences between acupuncture and control in trials without sham (placebo) control were both statistically and clinically significant. Acupuncture was significantly superior to sham control, suggesting that acupuncture effects are not solely explicable in terms of placebo, although these differences were relatively modest. We have separately reported secondary analyses examining whether characteristics of acupuncture treatment 65 or control groups 68 influence effect size, and whether the effects of acupuncture treatment persist over time 69 .
Here we update our prior analyses now including studies published during the last 7 years.
Methods
The full protocol of the meta-analysis 93 and the results of the first individual patient data meta-analysis including RCTs published up to November 2008 92 have been published. The literature search was repeated to identify eligible RCTs published between December 2008 and December 2015. Trials were considered eligible if they accrued patients with nonspecific back or neck pain, shoulder pain, chronic headache, or osteoarthritis; pain duration was at least 4 weeks for musculoskeletal disorders; at least one group received acupuncture needling and one group received either sham acupuncture or no acupuncture control; the primary endpoint was measured more than 4 weeks after the initial acupuncture treatment; and allocation concealment was determined unambiguously to be adequate. Principal investigators of eligible studies were asked to provide raw data. These raw data were used to replicate all analyses published in the original RCT publication to ensure data accuracy. Each trial was reanalyzed by analysis of covariance with the standardized primary endpoint (scores divided by pooled standard deviation) as the dependent variable, and the baseline measure of the primary endpoint and variables used to stratify randomization as covariates. The primary outcome for each study was that identified by the responding author of each study. The effect sizes for each study were then entered into a meta-analysis using the metan command in Stata (version 13, StataCorp, College Station, TX). Both fixed effects and random effects estimates were calculated. Fixed effects weights were calculated using inverse-variance weighting, and random effects weights were calculated using the DerSimonian and Laird method. We pre-specified that meta-analyses would be conducted separately for comparisons of acupuncture vs. sham and acupuncture vs. no acupuncture control, and within each pain type, and the hypothesis test would be based on the fixed effects analysis. In the original paper, trials for which individual patient data were not available were included as a sensitivity analysis; in this update, we include summary data for these trials in the main meta-analysis and exclude them as a sensitivity analysis.
As secondary analyses, we examined whether characteristics of acupuncture treatment modified treatment effects.
Both trial-level and patient-level analyses were performed. For trial-level analyses, we used random-effects metaregression to test the effect of each characteristic on the main effect estimate using the Stata command metareg. For patient-level analyses, we created a linear regression as for the main analysis of effect size, but included the characteristic and an interaction term between the characteristic and treatment allocation. The coefficient was then entered into a meta-analysis. In both analyses, random effects estimates and 95% confidence intervals were reported; p values are based on the fixed effects analysis. We also analyzed the effect of acupuncture relative to different types of sham acupuncture and different types of no acupuncture control group. Three comparisons of sham acupuncture were investigated: penetrating needle vs both non-penetrating needle and non-needle sham; non-penetrating needle vs nonneedle sham; and the use of true acupuncture points vs non-acupuncture points among trials using non-penetrating or non-needle sham. For sham arms using penetrating needles, there was also a comparison done between the use of deep needle penetration and shallow needle penetration. We entered the effect size and standard error for each trial into a meta-regression along with the type of sham acupuncture used in that trial. For this analysis, smaller effect sizes indicate a smaller difference in effect between verum acupuncture and sham acupuncture, implying that the type of sham acupuncture used is more active and therefore more similar to verum acupuncture. For the analysis of acupuncture effect relative to no acupuncture control group, we used meta-regression to compare the effects of trials using no acupuncture control groups characterized as high intensity, usual care, or low intensity. We also repeated our prior analyses exploring possible effects of publication bias and exploring difference between sham acupuncture and no treatment.
Results

Systematic Review
Our systematic review 93 was updated to include trials published after November 2008 and before December 31, 2015.
We identified 75 additional RCTs, of which 13 were eligible ( Figure 1 ). These 13 studies include four trials 19, 56, 75, 85 included as summary data only in a sensitivity analysis in our first report.
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Data Extraction and Quality Assessment
Individual patient data for 2,905 patients were received from 10 of these 13 studies and included patients from the United States, Australia, China, Germany and the UK. For one of the three studies for which we did not receive data, the statisticians involved in the RCT failed to respond to repeated enquiries despite approval for data sharing being obtained from the principal investigator. For the other two studies, the trial authors were contacted and invited to participate but we received no further response. These three studies were included in the analysis as summary data only using the published estimates of effect size. 31, 70, 75 Two trials from the original systematic review for which data were not received were also included as summary data in these analyses.
23, 74
A total of 20,827 patients were included in the total 39 trials ( Table 1 ). The trials comprised 25 comparisons with 16,041
patients of acupuncture and no acupuncture control, and 26 comparisons with 7,237 patients of acupuncture and sham acupuncture control. Of the trials on musculoskeletal pain, most had an eligibility criterion of a minimum 3 or 6 months pain duration. Amongst those for which individual patient data on chronicity were available, the median duration was 4 years (quartiles: 1.1 years, 10 years). There were two trials for which the time period between first symptom and evaluation of outcome could theoretically have been less than three months based on eligibility criteria and timing of assessment. For Irnich et al., the duration of disease was "4 -52 weeks" for 19% of patients and longer than one year for the remainder. 41 In the case of Kleinhenz et al., no data were provided on chronicity, however, the indication was rotator cuff tendinitis, which is rarely treated in the acute phase. 52 We conclude that all but a trivial proportion of patients included in the analysis would have met the conventional definition of chronic pain, that is, pain lasting at least 3 to 6 months. Six sham RCTs were determined to have an intermediate likelihood of bias from unblinding. 13, 26, 41, 49, 59, 103 In one trial, two types of sham acupuncture were used, although only one type (non-needle sham acupuncture) was found to have an intermediate likelihood of bias from unblinding. 103 One trial (Hinman et al.) was determined to have a sham acupuncture arm with a high likelihood of bias from unblinding. 39 This trial was excluded from the main analyses comparing acupuncture to sham acupuncture, but a sensitivity analysis including this trial was performed. None of the 10 new trials included in this analysis had dropout rates of higher than 25%.
Meta-analysis
Forest plots for acupuncture against sham acupuncture and against no acupuncture control are shown separately for each of the 4 pain conditions in Figure 2 and Heterogeneity is further explored below ("Modifiers of Trial Outcome").
Sensitivity Analyses
Prespecified sensitivity analyses are also shown in data, all had very similar results to the primary analysis. As the primary outcome included in the analysis was the outcome specified by the trial authors, we also performed a sensitivity analysis restricted to a single endpoint (pain intensity) at a fixed follow-up time (2 -3 months after randomization). Results were again very similar apart from shamcontrolled trials of musculoskeletal pain (Table 3) , where effect size decreased from 0.30 to 0.13, but this appears to be attributable to there being only 5 out of 11 trials that measured pain intensity at 2-3 months, and the trials excluded happened to be those with the larger effect sizes.
We combined all trials into one meta-analysis for all indications to assess the possible effect of publication bias. As in the original analyses, we found some evidence that smaller studies had larger effect sizes for the sham comparison (p=0.024), but not for the no acupuncture comparisons (p=0.75). No significant asymmetry was seen after excluding the Vas trials and shoulder pain trials from the sham comparison (N=21, p=0.13), and also when excluding any trials with fewer than 100 patients (N=21, p=0.069). We found that the difference between acupuncture and control would become non-significant only if there were 51 and >100 unpublished trials with 100 patients and effect sizes in favor of control of 0.25 SD for sham and no acupuncture control respectively.
We also repeated our exploratory analysis comparing sham control with no acupuncture control. In a meta-analysis of 12 RCTs that had both sham and no acupuncture control arms, the effect sizes for sham were 0.39 (95% CI 0.33, 0.45) and 0.45 (95% CI 0.29, 0.61) for fixed and random effects, respectively (p<0.0001 for tests of both effect and heterogeneity).
Modifiers of trial outcome
In addition to updating the primary analyses, we also updated previously published analyses on how characteristics of the acupuncture and control interventions influence trial outcomes. Trial-level and patient-level characteristics are found in Tables 4 and 5 , respectively.
Acupuncture Characteristics Analysis
We updated previously reported analyses examining whether characteristics of acupuncture treatment modified the effect of acupuncture relative to control. These analyses include both trial-level analysis, based on characteristics described in the study protocol, and patient-level analyses, based on data related to the individual patient. The results are shown in Table 6 . We did not find any obvious association between trial outcome and characteristics such as the style of acupuncture (Traditional or Western), use of fixed versus individualized point selection or the use of electrical stimulation. The only clear finding was a dose-response effect to number of acupuncture treatments in trials with a no acupuncture control group (increase in effect size of 0.10 per five sessions, 95% CI -0.01, 0.21, p=0.001).
Sham Acupuncture Control Analysis
We also updated a previously published analysis looking at the effects of acupuncture relative to different types of sham acupuncture and no acupuncture control groups. Differences in effect between acupuncture and the different sham acupuncture groups are found in Table 7 . The largest difference in effect between acupuncture and sham acupuncture was seen in trials using non-penetrating needles, while the smallest difference was seen in trials using needle penetration. Significant differences were found between trials using penetrating needle sham and those trials that used non-penetrating or non-needle sham (difference in SD -0.30, 95% CI -0.60, -0.00, p=0.047), although this result was sensitive to the exclusion of the outlying Vas trials (difference in SD -0.07, 95% CI -0.24, 0.10, p=0.4, Table 8 ), two of which used non-penetrating controls.
No Acupuncture Control Analysis
In addition to updating the analysis comparing types of sham acupuncture control, we also updated the analysis comparing types of no acupuncture control. We updated the categorization of no acupuncture control groups, and categorized trials as having a high intensity, usual care, or low intensity control group. In a "high intensity" control group, patients received a specified course of protocol-guided treatment. For instance, the UK APEX trial by Foster et al. 33 is considered a high intensity control because patients were randomized to receive a course of individualized, supervised physical therapy plus acupuncture vs. physical therapy alone. In a trial with "usual care" control, patients are able to access whatever care they might reasonably receive outside of the study. As an example, in the UK NHS study, patients were randomized to "use" vs. "avoid" acupuncture and could receive whatever other treatments were offered to them. 95 A control group was defined as "low intensity" if patients were not allowed to receive certain treatments that might otherwise be available. For instance, the Acupuncture Randomized Trials for low back pain and osteoarthritis limited treatment of pain in the control group to oral nonsteroidal anti-inflammatory drugs, excluding other types of treatment, such as steroids and other classes of analgesics. 11, 108 Trials were assessed and assigned a control group type by three collaborators, with disagreements resolved by consensus. One trial was excluded from this analysis as there was a reasonable argument that it involved active control, prespecified to be excluded. 26 Differences in effect between acupuncture and no acupuncture control groups are presented in Table 7 . Significant differences were found between acupuncture and control for all types of no acupuncture control group. Notably, however, in trials that had high intensity control groups, acupuncture had smaller effect sizes compared to those with low intensity controls groups (difference -0.81, 95% CI -1.26, -0.36, p=0.0004); similarly in trials with usual care control acupuncture had smaller effect sizes than trials with a low intensity control group (difference in SD -0.65, 95% CI -0.98, -0.31, p=0.0002, Table 8 ).
Time Course of Acupuncture Effects Analysis
We updated a previously published analysis assessing change in the effects of acupuncture over time relative to sham acupuncture and no acupuncture control 69 . Number of weeks of acupuncture treatment and the time points used in this analysis are reported in Table 9 . A total of 14 trials and 4,124 patients were included in the analysis of acupuncture vs no acupuncture control. The fixed-effects estimate for the between-group comparison of acupuncture vs no acupuncture controls showed a decrease in the effect size of acupuncture of 0.019 SD per 3 months (95% CI -0.041, 0.003, p=0.096, p=0.011 for heterogeneity, Figure 4a ). Given a difference between acupuncture and no acupuncture control of around 0.5 SD, this is equivalent to about a 15% decrease in acupuncture effect relative to control at 1 year after randomization, which was usually between 9 and 10 months after the end of treatment. In the analysis of acupuncture vs sham acupuncture, a total of 21 trials and 6,276 patients were included. There was a non-significant decrease of 0.012 SD per 3 months in acupuncture relative to sham acupuncture (95% CI -0.035, 0.011, p=0.3, Figure 4b ), about a 25% decrease in acupuncture effect at 1 year after randomization. Significant heterogeneity among trials was seen (p<0.0001). The previous analysis found that the decrease in effect of acupuncture relative to sham was driven by the decrease in neck pain trials (a decrease of 0.587 SD per 3 months, 95% CI -0.767, -0.406, p<0.0001). We also analyzed the change in acupuncture relative to sham excluding these trials and found a non-significant decrease of -0.003 SD per 3 months (95% CI -0.026, 0.020, p=0.8) with no significant heterogeneity among trials (p=0.12). Hence almost all the decrease in acupuncture effects in this analysis seems attributable to neck pain.
As a sensitivity analysis, we repeated the analyses including only trials that found a significant difference between acupuncture and control, as trials that showed no difference between groups cannot show a reduction in acupuncture effects over time. Nine trials with 2,997 patients were included in this analysis for the comparison between acupuncture and no acupuncture controls. A smaller and still non-significant decrease in the effect of acupuncture was found (-0.008 SD per 3 months, 95% CI -0.034, 0.018, p=0.5) and heterogeneity between trials was reduced (p=0.082). None of the newly included trials showed a significant effect of acupuncture vs sham and so this analysis of sham-controlled trials with a significant effect contains the same 7 trials and 1,450 patients and has the same results as reported in the original publication (-0.049 SD per 3 months, 95% CI -0.086, -0.013, p=0.008, heterogeneity p<0.0001).
Discussion
We updated an individual patient data meta-analysis of high-quality trials of acupuncture for chronic pain with seven additional years of data. An additional 10 studies were included with nearly 3,000 patients. In total, our analyses include 39 studies and 20,827 patients. The results confirm and strengthen prior key findings that acupuncture has a clinically relevant effect compared to no acupuncture control. Moreover, we confirmed that, although the effects of acupuncture are not completely explicable in terms of placebo effects, factors other than the specific effects of needling at correct acupuncture point locations are important contributors to acupuncture treatment benefit. Effects of acupuncture appear to persist over at least a 12 month period.
Heterogeneity continues to be an obvious aspect of our findings, with the results of trials varying by more than would be expected by chance. We have presented data that heterogeneity is predominately driven by differences between control groups rather than by differences between acupuncture treatment characteristics. We did not find any obvious differences between the results of trials depending on treatment characteristics such as style of acupuncture, duration of treatment sessions or training of acupuncturists. By contrast, we found evidence that effect sizes of acupuncture were smaller for sham-controlled trials with penetrating needles and for no acupuncture control trials where patients received high intensity care (e.g. a trial of acupuncture plus physical therapy vs. physical therapy alone). In some cases, heterogeneity was also driven by a set of outlying trials with large effect sizes. We have presented these analyses with and without the outlying trials to provide all necessary information for interpreting these results and drawing conclusions.
Another novel finding is the higher than average effects of acupuncture on upper body musculoskeletal pain. We now have sufficient data to conduct a meta-analysis for neck pain and for shoulder pain, even after exclusion of outlying trials. The effect sizes versus sham, 0.57 for shoulder and 0.83 for neck pain, were much larger than seen for low back pain, osteoarthritis and headache, although we also saw evidence that treatment benefits did not persist for neck pain.
Since publication of our results, there has been no substantive critique of our methodology in the peer-reviewed literature. The main issue under discussion seems to be whether the effect size of acupuncture is clinically relevant , evidence that the non-specific effects of acupuncture are particular to acupuncture and are not easily reproduced 46, 54 and evidence provided here and elsewhere 9 that some interventions used as sham acupuncture may be physiologically active.
It is also illustrative to compare our results to those of other interventions routinely used in clinical practice. For instance, in one meta-analysis of non-steroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis of the knee, the effect size for NSAIDs vs placebo for trials that did not preselect NSAID responders was 0.23; 10 for chronic low back pain, the effect size for NSAIDs is < 0.20 29 .
We find several implications for research. In terms of the methodology of subsequent acupuncture trials for chronic pain, we find that the balance of evidence is to give a higher dose of acupuncture in terms of a greater number of treatments in trials without sham control. Although the nature of the control group in trials will naturally be driven by the research question, investigators should be aware of the evidence that control arms that incorporate a relatively intense level of intervention, such as when acupuncture is added into an intensive rehabilitation regimen, tend to lead to smaller effect sizes, as do sham controls that involve needle penetration. Further research is warranted on whether acupuncture is particularly effective for upper body musculoskeletal pain. An associated hypothesis is whether there are subtypes of other chronic pain indications that have differential response to acupuncture. It would naturally be ideal to know before referring a patient for treatment whether, say, the type of back pain they are experiencing is one that would be amenable to treatment with acupuncture. We will also repeat our prior call for research on how best to incorporate acupuncture into the multidisciplinary care of chronic pain patients.
In terms of implications for clinical practice, we have confirmed that acupuncture has a clinically relevant, persistent effect on chronic pain that is not completely explained by placebo effects. Referral for a course of acupuncture treatment is therefore a reasonable option for a patient with chronic pain.
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